HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel L Mulkerin Selected Research

Bevacizumab (Avastin)

1/2017Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel L Mulkerin Research Topics

Disease

17Neoplasms (Cancer)
01/2021 - 08/2003
5Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 07/2010
3Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2020 - 01/2011
2Adenocarcinoma
01/2021 - 08/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 08/2015
2Liver Diseases (Liver Disease)
07/2013 - 02/2008
2Diarrhea
07/2010 - 06/2007
1Biliary Tract Neoplasms (Biliary Tract Cancer)
08/2013
1Carcinoid Tumor (Carcinoid)
01/2011
1Bipolar Disorder (Manic Depressive Psychosis)
01/2011
1Mucositis
07/2010
1Neutropenia
06/2009
1Sepsis (Septicemia)
06/2007
1Febrile Neutropenia
06/2007
1Leiomyosarcoma
06/2007
1Carcinoma (Carcinomatosis)
06/2007
1Trismus (Lockjaw)
08/2003

Drug/Important Bio-Agent (IBA)

7Capecitabine (Xeloda)FDA Link
01/2021 - 08/2003
6Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2017 - 06/2007
2Leucovorin (Folinic Acid)FDA Link
01/2017 - 07/2010
2Cetuximab (Erbitux)FDA Link
01/2017 - 04/2016
2Fluorouracil (Carac)FDA LinkGeneric
01/2017 - 07/2010
2Sorafenib (BAY 43-9006)FDA Link
08/2015 - 08/2013
2Imatinib Mesylate (Gleevec)FDA Link
02/2008 - 02/2008
1Temozolomide (Temodar)FDA LinkGeneric
10/2020
1trifluridine tipiracil drug combinationIBA
10/2020
1ErbB Receptors (EGF Receptor)IBA
12/2018
1AntibodiesIBA
12/2018
1Biomarkers (Surrogate Marker)IBA
12/2018
1Biological ProductsIBA
01/2017
1Monoclonal AntibodiesIBA
01/2017
1Irinotecan (Camptosar)FDA LinkGeneric
01/2017
1Bevacizumab (Avastin)FDA Link
01/2017
1AZD 6244IBA
04/2016
1Histone Deacetylase InhibitorsIBA
01/2016
1PanobinostatIBA
01/2016
1Histone Deacetylases (Histone Deacetylase)IBA
01/2016
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
02/2015
12,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA
02/2015
1pazopanibFDA Link
07/2013
1Lithium ChlorideIBA
01/2011
1LithiumIBA
01/2011
1Chromogranin AIBA
01/2011
1GemcitabineFDA Link
06/2009
1Dihydrotachysterol (AT 10)IBA
06/2009
1BilirubinIBA
02/2008
1CreatinineIBA
02/2008
1Paclitaxel (Taxol)FDA LinkGeneric
06/2007
17- cyano- 2,3,4,5- tetrahydro- 1- (1H- imidazol- 4- ylmethyl)- 3- (phenylmethyl)- 4- (2- thienylsulfonyl)- 1H- 1,4- benzodiazepine (BMS 214662)IBA
06/2007
1Transaminases (Aminotransferases)IBA
06/2007
1Hormones (Hormone)IBA
06/2007

Therapy/Procedure

7Drug Therapy (Chemotherapy)
05/2019 - 01/2011
4Therapeutics
12/2018 - 01/2011
1Neoadjuvant Therapy
01/2021
1Premedication
05/2019
1Biological Therapy
01/2017
1Precision Medicine
09/2015